##STR1## Novel antiviral compounds of formulae (1A) and (1B), wherein X and R.sub.1 -R.sub.4 are as stated in claim 1 in the form of an .alpha.- or .beta.-anomer or a mixture thereof, and pharmaceutically acceptable salts thereof, are disclosed, as well as a new method for preparation thereof. Said compounds can be used for treatment of infections caused by viruses requiring reverse transcriptase for replication, such as HIV and hepatitis B virus.
本发明公开了式(1A)和(1B)的新型抗病毒化合物,其中X和R.sub.1-R.sub.4如权利要求书中所述,以α-或β-异构体或其混合物的形式存在,并且其药物可接受的盐,以及其制备的新方法。所述化合物可用于治疗由需要
反转录酶复制的病毒引起的感染,例如HIV和乙型肝炎病毒。